BRD4354

CAS No. 315698-07-8

BRD4354 ( BRD 4354 )

Catalog No. M14024 CAS No. 315698-07-8

BRD4354 is a moderately potent, selective, reversible inhibitor of HDAC5 and HDAC9 with IC50 of 0.85 uM and 1.88 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 Get Quote
5MG 58 Get Quote
10MG 102 Get Quote
25MG 205 Get Quote
50MG 357 Get Quote
100MG 530 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BRD4354
  • Note
    Research use only, not for human use.
  • Brief Description
    BRD4354 is a moderately potent, selective, reversible inhibitor of HDAC5 and HDAC9 with IC50 of 0.85 uM and 1.88 uM.
  • Description
    BRD4354 is a moderately potent, selective, reversible inhibitor of HDAC5 and HDAC9 with IC50 of 0.85 uM and 1.88 uM; shows weak activity against HDACs 4, 6, 7, and 8 (IC50=3.88-13.8 uM) and no inhibitory effect on other class I HDACs 1, 2, and 3 (IC50 > 40 uM).
  • Synonyms
    BRD 4354
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    315698-07-8
  • Formula Weight
    382.89
  • Molecular Formula
    C21H23ClN4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 125 mg/mL326.46 mM;
  • SMILES
    OC1=C2N=CC=CC2=C(Cl)C=C1C(N3CCN(CC)CC3)C4=CC=CN=C4
  • Chemical Name
    5-chloro-7-((4-ethylpiperazin-1-yl)(pyridin-3-yl)methyl)quinolin-8-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Boskovic ZV, et al. ACS Chem Biol. 2016 Jul 15;11(7):1844-51.
molnova catalog
related products
  • M 344

    M344 is a potent HDAC inhibitor with IC50 of 100 nM and able to induce cell differentiation.

  • SS-208

    SS-208 is a selective inhibitor of HDAC6 (IC50 = 12 nM) with anti-tumor activity. SS-208 shows selectivity over other HDAC subtypes.

  • BRD2492

    BRD2492 is a highly potent, selective HDAC1/2 inhibitor (IC50=2/19 nM, respectively).